Stephen C. Hyde
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Using the nose as a factory to secrete proteins into the lungs or circulation.
Journal: Molecular therapy. Advances
Published: November 17, 2025
Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.
Journal: Gene therapy
Published: November 14, 2025
F/HN-pseudotyped lentiviral vector efficiently transduces non-human primate airways with no evidence of relevant toxicity.
Journal: Molecular therapy. Advances
Published: May 20, 2025
Single-cycle, pseudotyped reporter influenza virus to facilitate evaluation of treatment strategies for avian influenza, Ebola and other highly infectious diseases in vivo.
Journal: Frontiers in immunology
Published: April 08, 2025
Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial.
Journal: American journal of respiratory and critical care medicine
Published: September 05, 2024
Perceptions of online surgical-focused learning amongst surgeons during the COVID pandemic: A scoping review 2020-22.
Journal: The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
Published: October 05, 2023
Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy.
Journal: The European respiratory journal
Published: October 02, 2023
Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors.
Journal: Molecular therapy. Methods & clinical development
Published: April 10, 2022
Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice.
Journal: European journal of immunology
Published: March 20, 2022
Advances in e-learning in undergraduate clinical medicine: a systematic review.
Journal: BMC medical education
Published: February 26, 2022
Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression.
Journal: Molecular therapy. Methods & clinical development
Published: January 12, 2022
Last Updated: 09/26/2026